Tegaserod is a selective 5-HT4 receptor agonist primarily indicated for the treatment of irritable bowel syndrome with constipation in women under 65 years of age. This category provides comprehensive… Read more










Tegaserod is a selective 5-HT4 receptor agonist primarily indicated for the treatment of irritable bowel syndrome with constipation in women under 65 years of age. This category provides comprehensive analytical support through a range of pharmaceutical reference standards, including the active pharmaceutical ingredient, its maleate salt, and essential related compounds. Analytical chemists rely on these high-quality materials for impurity profiling, ensuring rigorous quality control during formulation and stability testing. The availability of diverse metabolites and stable isotope-labelled compounds is critical for method validation, particularly when conducting pharmacokinetic studies or accurately quantifying degradation products in complex matrices. These reference materials facilitate precise regulatory compliance and the systematic characterization of metabolic pathways, supporting laboratories in maintaining the highest standards for the development and assessment of this therapeutic agent.